Prabakaran, Mookkan <br/><br/>
Combination therapy using chimeric monoclonal antibodies protects mice from lethal H5N1 infection and prevents formation of escape mutants.  [electronic resource] 

 -  PloS one  May 2009 
 - e5672 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0005672  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Viral--administration & dosage<br/>Cell Line<br/>Dogs<br/>Dose-Response Relationship, Drug<br/>Drug Therapy, Combination<br/>Humans<br/>Immunization, Passive<br/>Influenza A Virus, H5N1 Subtype--genetics<br/>Lung--pathology<br/>Mice<br/>Mutation--genetics<br/>Neutralization Tests<br/>Orthomyxoviridae Infections--drug therapy<br/>Reassortant Viruses--genetics<br/>Recombinant Fusion Proteins--administration & dosage